OKG Capital
Investment firm focused on supporting early-stage healthcare companies, prioritizing chronic disease therapeutics and diagnostics with an emphasis on oncology. Provides active collaboration with pharmaceutical partners, clinical networks, and foundations and supports projects spanning preclinical and clinical drug discovery, diagnostics, medical imaging, and remote patient monitoring.
Industries
Venture Capital and Private Equity Principals
Nr. of Employees
small (1-50)
Services
Hands-on advisory to founders on finance, commercial strategy, investor relations, and strategic partnerships.
Support for capital raising strategy and financial analysis for portfolio companies.
Facilitating collaborations with pharmaceutical companies, clinical networks and charitable foundations.
Hands-on advisory to founders on finance, commercial strategy, investor relations, and strategic partnerships.
Support for capital raising strategy and financial analysis for portfolio companies.
Facilitating collaborations with pharmaceutical companies, clinical networks and charitable foundations.
Expertise Areas
- Oncology drug discovery
- CNS therapeutic development
- Preclinical and clinical-stage development
- Diagnostics development (proteomics, antimicrobial resistance)
Key Technologies
- Proteomics
- Advanced medical imaging
- Molecular diagnostics
- Remote patient monitoring systems